Fueling Transformative Healthcare Companies With Investment in Invention.
We fund exceptional teams developing compelling, well-protected innovations that will significantly impact the healthcare system.

Strategy & Approach

Grey Sky Venture Partners focuses on discovering and funding exceptional management teams developing compelling, well-protected innovations springing from leading-edge research that have the potential to significantly impact the complex and rapidly changing healthcare system.

We make early-stage investments in healthcare and medical technology companies that seek to improve clinical outcomes, enhance quality of life, or reduce system costs. With a heritage rooted in invention, Grey Sky also brings intellectual property expertise and access to a patent portfolio that can be strategically valuable to young companies.

About GreySky

Grey Sky identifies new early-stage investment opportunities by tapping into a broad network of industry relationships and through screened thematic research into emergent diagnostic and therapeutic areas in healthcare. Following our initial investment, we work closely with portfolio companies and syndicate partners to develop and implement strategic plans, achieve operating objectives, build great teams, raise additional capital, and pursue liquidity opportunities in a manner that optimizes returns to all stakeholders.

Our company name was inspired by the frequently cloudy skies of the verdant Pacific Northwest, a region to which the fund has important ties.

Investment Portfolio

HepaTX

Details

Westface

Details

Quantum Diamond Technologies

Details

Modulim

Details
Altoida

Altoida

Details

MatriSys Bioscience

Details

Persephone Biome

Details

Biolinq

Details

Immunovalent

Details
Travera

Travera

Details

Carewave Medical

Details
Inflammatix

Inflammatix, Inc

Details

Nodexus

Details

Sonavex

Details

Winterlight

Details

AmacaThera

Details

GreySky Team

 

Michael Banks

Founder & Partner

Michael is a Founder and Partner at Grey Sky Venture Partners. Prior to Grey Sky, Michael helped launch two of the top strategic venture firms in the world (Intel Capital and Steamboat Ventures), two successful private venture capital funds (Palisades Ventures and DE Shaw Ventures) and seed capital fund Windy Hill Capital.

More→

At Intel Capital, Michael managed a team of 20 professionals investing in advanced technologies for the Architecture Labs and New Business Group. At Disney’s Steamboat Ventures and at Palisades Ventures, Michael was a partner leading investments in a variety of digital technology categories.

In 2007, Michael joined DE Shaw Ventures to run media investments, and in 2012, Michael launched Windy Hill Capital, a seed fund focused on investments in advanced HW and SW technologies. Prior to venture capital, Michael was an entrepreneur and consultant.

Michael earned his MA and BA from Stanford University and his MBA from The Anderson School.

←Less

Paul Wu

Paul Wu

Partner

Paul is a Partner at Grey Sky Venture Partners. His diverse background has spanned across the biomedical and technology sectors as an inventor, entrepreneur, business development professional, and venture investor. Previously, he worked at the Invention Science Fund, an invention and intellectual property investment company.

More→

While there, he worked at the intersection of healthcare and technology innovation and was responsible for in-depth market analyses and strategic business development.

Earlier in his career, Paul was a member of the Strategic Business Unit at KLA-Tencor where he managed B2B relationships, product development and global launches at key customer sites such as Intel Corporation and TSMC.

Paul holds an MBA from the MIT Sloan School of Management and a PhD in Biomedical Engineering from Northwestern University.

←Less

 

Contact GreySky

Contact Info